Suchergebnisse - "Zala, Carlos"

PubPharm (63)

1

Erratum for Angel et al., "Early Diagnosis of Toxoplasmic Encephalitis in AIDS Patients by Dot Blot Hybridization Analysis"

enthalten in: Journal of clinical microbiology | 2023

von Angel, S. | Maero, E. | Blanco, J. | +5

ErratumFor: J Clin Microbiol. 1992 Dec;30(12):3286-7. - PMID 1452719

2

Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response

enthalten in: The Journal of infectious diseases | 2022

von Varese, A. | Mazzitelli, B. | Erra Díaz, F. | +19

3

Cohort of pregnant and postpartum women with COVID-19. Comparative analysis between two pandemic waves

enthalten in: Medicina | 2022

von Barris, M. | Figueras, L. | Zala, C. | +3

4

P6.21 Thinking of new strategies towards the end of prenatal hiv in argentina. ministry of health, aids and stis program

enthalten in: Sexually transmitted infections | 2017

von Silvina Vulcano | Bruno Miriam | Gaiano Alejandra | +2

5

Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks

enthalten in: Clinical drug investigation | 2015

von Quercia, R. | Roberts, J. | Martin-Carpenter, L. | +1

6

Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks

enthalten in: Clinical drug investigation | 2015

von Quercia, R. | Roberts, J. | Martin-Carpenter, L. | +1

7

Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks

enthalten in: Clinical drug investigation | 2015

von Quercia, R. | Roberts, J. | Martin-Carpenter, L. | +1

8

Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings

enthalten in: BMC infectious diseases | 2012

von Calmy, A. | Balestre, E. | Bonnet, F. | +27

9

Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings

enthalten in: BMC infectious diseases | 2012

von Calmy, A. | Balestre, E. | Bonnet, F. | +16

10

Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings

enthalten in: BMC infectious diseases | 2012

von Calmy, A. | Balestre, E. | Bonnet, F. | +16

1
2
3
4
5
6
7
Nächster »
[7]